Literature DB >> 29167619

Exenatide Inhibits the KCa3.1 Channels of Aortic Vascular Smooth Muscle in Diabetic Rats.

Peng Dong1, Minglong Liu2, Chaofeng Liu3.   

Abstract

BACKGROUND: KCa3.1 ion channels play an important role during atherosclerosis. We aimed to investigate the effect of exenatide on KCa3.1 expression in aortic vascular smooth muscle cells (VSMCs) of diabetic rats.
METHODS: Sprague-Dawley rats were randomly divided into normal control (NC), diabetes model (DM), and exenatide treatment (ET) groups. Hematoxylin and eosin and α-actin immunohistochemical staining were used to detect changes in rat aortic vascular smooth muscle. Quantitative RT-PCR and Western blot analysis were used to detect changes in KCa3.1 mRNA and protein levels, respectively.
RESULTS: Aortic tissue staining in the DM group revealed an absence of smooth or integrated endothelium, increased smooth muscle cell proliferation in the media, smooth muscle hyperplasia, disorganized smooth muscle cells, and an increased number of collagen fibers, relative to the NC and ET groups. KCa3.1 mRNA expression was higher in the DM group than in the NC and ET groups. Similarly, the KCa3.1 protein level was higher in the DM group than in the NC and ET groups. The KCa3.1 protein level did not significantly differ between the ET and NC groups.
CONCLUSIONS: Exenatide could inhibit the expression of the KCa3.1 channel in VSMCs of diabetic rats.

Entities:  

Keywords:  Atherosclerosis; Ion channel; Vascular smooth muscle cells

Year:  2017        PMID: 29167619      PMCID: PMC5694930          DOI: 10.6515/ACS20170612B

Source DB:  PubMed          Journal:  Acta Cardiol Sin        ISSN: 1011-6842            Impact factor:   2.672


  37 in total

1.  Molecular cloning and characterization of the intermediate-conductance Ca(2+)-activated K(+) channel in vascular smooth muscle: relationship between K(Ca) channel diversity and smooth muscle cell function.

Authors:  C B Neylon; R J Lang; Y Fu; A Bobik; P H Reinhart
Journal:  Circ Res       Date:  1999-10-29       Impact factor: 17.367

2.  Mononuclear phagocyte biophysiology influences brain transendothelial and tissue migration: implication for HIV-1-associated dementia.

Authors:  Induk Chung; Marina Zelivyanskaya; Howard E Gendelman
Journal:  J Neuroimmunol       Date:  2002-01       Impact factor: 3.478

3.  A new rat model of type 2 diabetes: the fat-fed, streptozotocin-treated rat.

Authors:  M J Reed; K Meszaros; L J Entes; M D Claypool; J G Pinkett; T M Gadbois; G M Reaven
Journal:  Metabolism       Date:  2000-11       Impact factor: 8.694

4.  Experimental diabetes mellitus down-regulates large-conductance Ca2+-activated K+ channels in cerebral artery smooth muscle and alters functional conductance.

Authors:  Yan Wang; Hong-Tao Zhang; Xing-Li Su; Xiu-Ling Deng; Bing-Xiang Yuan; Wei Zhang; Xin-Feng Wang; Yu-Bai Yang
Journal:  Curr Neurovasc Res       Date:  2010-05       Impact factor: 1.990

5.  Upregulation of intermediate-conductance Ca2+-activated K+ channel (IKCa1) mediates phenotypic modulation of coronary smooth muscle.

Authors:  D L Tharp; B R Wamhoff; J R Turk; D K Bowles
Journal:  Am J Physiol Heart Circ Physiol       Date:  2006-06-23       Impact factor: 4.733

6.  KCa3.1 channels mediate the increase of cell migration and proliferation by advanced glycation endproducts in cultured rat vascular smooth muscle cells.

Authors:  Li-Mei Zhao; Xing-Li Su; Yan Wang; Gui-Rong Li; Xiu-Ling Deng
Journal:  Lab Invest       Date:  2012-11-19       Impact factor: 5.662

7.  Reversible inhibition of the platelet procoagulant response through manipulation of the Gardos channel.

Authors:  Jef L Wolfs; Simone J Wielders; Paul Comfurius; Theo Lindhout; John C Giddings; Robert F Zwaal; Edouard M Bevers
Journal:  Blood       Date:  2006-06-01       Impact factor: 22.113

8.  [Ca(2+)-activated K(+) channel switching in smooth muscle participates in atherosclerosis development in diabetic rats].

Authors:  Yan Wang; Limei Zhao; Xingli Su; Wei Yu; Xiuling Deng
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2014-02

9.  Glucagon-like peptide-1 inhibits vascular smooth muscle cell dedifferentiation through mitochondrial dynamics regulation.

Authors:  Gloria Torres; Pablo E Morales; Marina García-Miguel; Ignacio Norambuena-Soto; Benjamín Cartes-Saavedra; Gonzalo Vidal-Peña; David Moncada-Ruff; Fernanda Sanhueza-Olivares; Alejandra San Martín; Mario Chiong
Journal:  Biochem Pharmacol       Date:  2016-01-22       Impact factor: 5.858

10.  Exenatide Protects Against Glucose- and Lipid-Induced Endothelial Dysfunction: Evidence for Direct Vasodilation Effect of GLP-1 Receptor Agonists in Humans.

Authors:  Juraj Koska; Michelle Sands; Camelia Burciu; Karen M D'Souza; Kalyani Raravikar; James Liu; Seth Truran; Daniel A Franco; Eric A Schwartz; Dawn C Schwenke; David D'Alessio; Raymond Q Migrino; Peter D Reaven
Journal:  Diabetes       Date:  2015-02-26       Impact factor: 9.461

View more
  2 in total

Review 1.  Ca2+ signalling in fibroblasts and the therapeutic potential of KCa3.1 channel blockers in fibrotic diseases.

Authors:  Katy M Roach; Peter Bradding
Journal:  Br J Pharmacol       Date:  2020-02-03       Impact factor: 8.739

Review 2.  Diabetes Mellitus and Ischemic Heart Disease: The Role of Ion Channels.

Authors:  Paolo Severino; Andrea D'Amato; Lucrezia Netti; Mariateresa Pucci; Marialaura De Marchis; Raffaele Palmirotta; Maurizio Volterrani; Massimo Mancone; Francesco Fedele
Journal:  Int J Mol Sci       Date:  2018-03-10       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.